Media

January 05, 2021 08:05 AM Eastern Standard Time ROCKVILLE, Md.--(BUSINESS WIRE)--Immunomic Therapeutics, Inc. (ITI), a privately held, Maryland-based biotechnology company, announced today that the company will present at the 13th Annual

December 09, 2020 04:05 PM Eastern Standard Time ROCKVILLE, Md.--(BUSINESS WIRE)--Immunomic Therapeutics, Inc., (“ITI”), a privately-held clinical-stage biotechnology company pioneering the study of nucleic acid immunotherapy platforms, and WhyWeVax™ (WWV),

ITI will be presening at the BIO CEO & Investor Digital Conference, February 16-18, 2021 For more than 20 years, the BIO CEO & Investor Conference has fueled biotech industry

ITI will be presenting at the Biotech Showcase January 11–15, 2021, Delivered Digitally, US Pacific Standard Time DISCOVER. INVEST. CURE. – DIGITAL INVESTOR CONFERENCE It's all happening here! Connecting investors

December 01, 2020 08:05 AM Eastern Standard Time ROCKVILLE, Md.--(BUSINESS WIRE)--Immunomic Therapeutics, Inc. (ITI) announced today that it will be presenting at the 2nd Annual Glioblastoma Drug Development Virtual Summit.

November 19, 2020 04:05 PM Eastern Standard Time ROCKVILLE, Md. & DURHAM, N.C.--(BUSINESS WIRE)--Immunomic Therapeutics, Inc., (“ITI”), a privately-held clinical-stage biotechnology company pioneering the study of nucleic acid immunotherapy platforms,

Poster Title: LAMP1 targeting of the large T antigen of Merkel cell polyomavirus elicits potent CD4+ T cell responses and prevents tumor growth Presentation Date: 11/11/2020 - 11/14/2020, 9:00 am

Longwood Healthcare Leaders meeting, April 5-6, 2021, centered on MIT’s Koch Institute via web conference with leading biopharma CEOs, heads of R&D, top academic researchers, and healthcare investors, co-hosted by

The SNO annual meeting is the world’s largest neuro-oncology conference, attracting over 2400 researchers and clinician-scientists from all neuro-oncology disciplines, professionals, and interests from more than 40 countries.  The meeting

The Society for Immunotherapy of Cancer’s (SITC) 36th Annual Meeting & Pre-Conference Programs (SITC 2021) will take place on Nov. 10–14, 2021, at the Walter E. Washington Convention Center in Washington,

The ESMO Congress is the yearly appointment in Europe for nearly 30’000 clinicians, researchers, oncology nurses, patient advocates, journalists, and representatives of the pharmaceutical industry from all over the world

World Vaccine Congress remains the industry’s definitive vaccine industry event for major vaccine players and their respective senior-level representatives More detailed information to come.